Precision Biosciences Inc's Comment on Supply Chain
Regulatory requirements for raw materials and clinical trials mandate approvals from foreign regulatory authorities prior to initiating clinical trials or marketing. Raw materials pose contamination risks, and regulatory processes differ among countries. Non-clinical studies must comply with EU Directive 2004/10/EC and Good Laboratory Practice (GLP) principles, aligned with OECD standards. Clinical trials conducted in the European Union are governed by EU and national regulations, International Council for Harmonisation (ICH) guidelines on Good Clinical Practices (GCPs), and additional European Commission guidelines specific to Advanced Therapy Medicinal Products (ATMPs). Sponsors located outside the EU are required to appoint an EU legal representative and provide clinical trial insurance and compensation. The EU Clinical Trials Regulation (CTR), effective January 31, 2022, harmonizes the assessment and supervision of clinical trials across EU member states through a centralized portal, replacing the previous directive that necessitated separate applications in each member state.
Precision Biosciences Inc's Comment on Supply Chain
Regulatory requirements for raw materials and clinical trials mandate approvals from foreign regulatory authorities prior to initiating clinical trials or marketing. Raw materials pose contamination risks, and regulatory processes differ among countries. Non-clinical studies must comply with EU Directive 2004/10/EC and Good Laboratory Practice (GLP) principles, aligned with OECD standards. Clinical trials conducted in the European Union are governed by EU and national regulations, International Council for Harmonisation (ICH) guidelines on Good Clinical Practices (GCPs), and additional European Commission guidelines specific to Advanced Therapy Medicinal Products (ATMPs). Sponsors located outside the EU are required to appoint an EU legal representative and provide clinical trial insurance and compensation. The EU Clinical Trials Regulation (CTR), effective January 31, 2022, harmonizes the assessment and supervision of clinical trials across EU member states through a centralized portal, replacing the previous directive that necessitated separate applications in each member state.
Sources:
Precision Biosciences Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Precision Biosciences Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
